Identification of Novel Biomarkers for Predicting Prognosis and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma Based on ceRNA Network and Immune Infiltration Analysis

Figure 2

Survival analysis of key members in the ceRNA network. (a–j) K-M survival curves for the significant members of the ceRNA network. (a) ACSL1, (b) CDCA4, (c) GNA12, (d) hsa-miR-29c-3p, (e) hsa-miR-130b-3p, (f) ITGA5, (g) KDELC1, (h) PRKAA2, (i) PRUNE2, and (j) PTX3.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)